Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study - Takeaways - MDSpire

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study

  • By

  • Gerome Vallejos

  • Carla Kim

  • Kathryn B Holroyd

  • Kiran T Thakur

  • December 11, 2025

  • 0 min

Share

  • 1

    Diagnosing meningitis and encephalitis is challenging due to nonspecific symptoms and limitations of traditional microbiological methods.

  • 2

    Metagenomic next-generation sequencing (mNGS) can detect a broad range of pathogens directly from cerebrospinal fluid.

  • 3

    Using mNGS could significantly reduce the number of microbiological tests and lumbar punctures needed for diagnosis.

  • 4

    In a modeled scenario, mNGS could decrease diagnosis time by up to 145 days for infectious cases and 297 days for autoimmune cases.

  • 5

    The study suggests that mNGS may streamline diagnostic and treatment pathways for central nervous system infections.

Original Source(s)

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study

  • by Gerome Vallejos, Carla Kim, Kathryn B Holroyd, Kiran T Thakur

  • December 11, 2025

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Introducing a New Polymerase Chain Reaction Panel–Based Cerebrospinal Fluid Evaluation for Encephalitis and Meningitis: Does It Influence Empiric Treatment Duration, Length of Hospital Stay, and Pathogen-Specific Diagnoses?

Molecular Mimicry Drives Locally Produced Autoantibodies in Subarachnoid Neurocysticercosis